{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:41:14Z","timestamp":1756460474107,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00467-021-05127-3","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T22:02:16Z","timestamp":1621288936000},"page":"2891-2894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fenoldopam and renal hemodynamics in shiga toxin-related hemolytic uremic syndrome"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0659-1206","authenticated-orcid":false,"given":"Gianluigi","family":"Ardissino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antenore","family":"Giussani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Capone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Montini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the ItalKid-HUS Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"5127_CR1","doi-asserted-by":"publisher","unstructured":"Ardissino G, Tel F, Possenti I, Testa S et al (2016) Early volume expansion and outcomes of hemolytic uremic syndrome. Pediatrics 137. https:\/\/doi.org\/10.1542\/peds.2015-2153","DOI":"10.1542\/peds.2015-2153"},{"key":"5127_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/j.1552-4604.1998.tb04369.x","volume":"38","author":"WH Frishman","year":"1998","unstructured":"Frishman WH (1998) Fenoldopam: a new dopamine agonist for the treatment of hypertensive urgencies and emergencies. J Clin Pharmacol 38:2\u201313. https:\/\/doi.org\/10.1002\/j.1552-4604.1998.tb04369.x","journal-title":"J Clin Pharmacol"},{"key":"5127_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2125.1988.tb03276.x","volume":"25","author":"RR Weber","year":"1988","unstructured":"Weber RR, McCoy CE, Ziemniak JA, Frederickson ED et al (1988) Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients. Br J Clin Pharmacol 25:17\u201321. https:\/\/doi.org\/10.1111\/j.1365-2125.1988.tb03276.x","journal-title":"Br J Clin Pharmacol"},{"key":"5127_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00045391-199909000-00007","volume":"6","author":"LM Strauser","year":"1999","unstructured":"Strauser LM, Pruitt RD, Tobias JD (1999) Initial experience with fenoldopam in children. Am J Ther 6:283\u2013288. https:\/\/doi.org\/10.1097\/00045391-199909000-00007","journal-title":"Am J Ther"},{"key":"5127_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00467-019-04368-7","volume":"35","author":"G Ardissino","year":"2020","unstructured":"Ardissino G, Ghiglia S, Salice P, Perrone M, Piantanida S, De Luca FL, Di Michele S, Filippucci L, Dardi ERA, Bollani T, Mezzopane A, Tchane B, Lava SAG, SPA Project investigators (2020) Multiple office blood pressure measurement: a novel approach to overcome the weak cornerstone of blood pressure measurement in children. Data from the SPA project. Pediatr Nephrol 35:687\u2013693. https:\/\/doi.org\/10.1007\/s00467-019-04368-7","journal-title":"Pediatr Nephrol"},{"key":"5127_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2174\/1389201020666190417124711","volume":"20","author":"A Noce","year":"2019","unstructured":"Noce A, Marrone G, Rovella V, Busca A et al (2019) Fenoldopam mesylate: a narrative review of its use in acute kidney injury. Curr Pharm Biotechnol 20:366\u2013375. https:\/\/doi.org\/10.2174\/1389201020666190417124711","journal-title":"Curr Pharm Biotechnol"},{"key":"5127_CR7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/B978-0-323-03961-1.50066-0","volume-title":"Comprehensive hypertension","author":"E Grossman","year":"2007","unstructured":"Grossman E, Masseri FH (2007) Chapter 63 - Hypertensive urgencies and emergencies. In: Lip GYH, Hall JE (eds) Comprehensive hypertension. Mosby, Maryland Heights, pp 761\u2013774. https:\/\/doi.org\/10.1016\/B978-0-323-03961-1.50066-0"},{"key":"5127_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2253-8-6","volume":"8","author":"GB Hammer","year":"2008","unstructured":"Hammer GB, Verghese ST, Drover DR, Yaster M et al (2008) Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients. BMC Anesthesiol 8:6. https:\/\/doi.org\/10.1186\/1471-2253-8-6","journal-title":"BMC Anesthesiol"},{"key":"5127_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.athoracsur.2009.09.071","volume":"89","author":"M Meco","year":"2010","unstructured":"Meco M, Cirri S (2010) The effect of various fenoldopam doses on renal perfusion in patients undergoing cardiac surgery. Ann Thorac Surg 89:497\u2013503. https:\/\/doi.org\/10.1016\/j.athoracsur.2009.09.071","journal-title":"Ann Thorac Surg"},{"key":"5127_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40620-018-0496-0","volume":"32","author":"V Rovella","year":"2019","unstructured":"Rovella V, Ferrannini M, Tesauro M, Marrone G, Busca A, Sorge R, Manca di Villahermosa S, Casasco M, Di Daniele N, Noce A (2019) Effects of fenoldopam on renal blood flow in hypertensive chronic kidney disease. J Nephrol 32:75\u201381. https:\/\/doi.org\/10.1007\/s40620-018-0496-0","journal-title":"J Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05127-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T10:11:43Z","timestamp":1629195103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05127-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5127"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05127-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"3 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical committee of our Institution provided the approval for the off-label use of fenoldopam.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent to treatment and to the publication of the results was obtained from all parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}